From Better Diagnostics to Earlier Treatment: The Rapidly Evolving Alzheimer's Disease Landscape.

Medicina (Kaunas) · 2025 · PMC12388077 · PMID 40870510

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a positive trendno p-value reported

Neflamapimod, an inhibitor of p38α kinase, demonstrated a positive trend for NRGN and reduced CSF levels of tTau and pTau181 in comparison to a placebo [ 29 ]. 2.2.

also in 11,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.